What is the treatment for acute gout (gouty arthritis) flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For treating a gout flare, the most effective approach is to start with an anti-inflammatory medication as soon as possible after symptoms begin, with colchicine, NSAIDs, or oral corticosteroids being first-line options. According to the 2020 American College of Rheumatology guideline for the management of gout 1, colchicine, nonsteroidal anti-inflammatory drugs, or glucocorticoids (oral, intraarticular, or intramuscular) are strongly recommended for managing gout flares. The choice of drug should be based on the presence of contraindications, the patient’s previous experience with treatments, time of initiation after flare onset, and the number and type of joint(s) involved, as recommended by the 2016 updated EULAR evidence-based recommendations for the management of gout 1.

Some key considerations for treatment include:

  • Colchicine should be started within 12 hours of flare onset, with a loading dose of 1 mg followed by 0.5 mg one hour later, then 0.5 mg once or twice daily until the flare resolves 1.
  • NSAIDs, such as naproxen or indomethacin, can be used as first-line options for most patients, but should be avoided in patients with severe renal impairment 1.
  • Oral corticosteroids, such as prednisone, can be used as an alternative for those who cannot take NSAIDs or colchicine, at a dose of 30-35 mg/day for 3-5 days 1.
  • During a flare, rest, ice, and hydration can help reduce pain and swelling.

It's essential to continue the chosen medication until the flare completely resolves, typically 7-10 days, and to discuss long-term urate-lowering therapy with a doctor to prevent future attacks, as recurrent gout flares can lead to joint damage over time.

From the FDA Drug Label

The recommended dose of Colchicine Tablets, USP for treatment of a gout flare is 1.2 mg (two tablets) at the first sign of the flare followed by 0.6 mg (one tablet) one hour later. Higher doses have not been found to be more effective. The maximum recommended dose for treatment of gout flares is 1.8 mg over a one hour period.

The treatment for acute gout (gouty arthritis) flare is 1.2 mg of colchicine at the first sign of the flare, followed by 0.6 mg one hour later. The maximum recommended dose is 1.8 mg over a one hour period 2.

  • Key points:
    • Initial dose: 1.2 mg
    • Second dose: 0.6 mg one hour later
    • Maximum dose: 1.8 mg over one hour
  • Important consideration: Higher doses have not been found to be more effective.

From the Research

Treatment Options for Acute Gout

The treatment for acute gout (gouty arthritis) flare includes several options, such as:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) 3, 4, 5, 6
  • Colchicine 3, 4, 5, 6
  • Corticosteroids (oral or intramuscular) 3, 4, 5, 6
  • Interleukin-1 inhibitors (e.g. canakinumab, rilonacept) 4, 6, 7

Considerations for Treatment

When selecting a treatment, several factors should be considered, including:

  • The patient's medical history and comorbidities 3, 4, 5, 6
  • The potential side effects of each treatment option 3, 4, 5, 6, 7
  • The cost and cost-effectiveness of each treatment option 7
  • The patient's preference and adherence to treatment 4, 6

Emerging Therapies

New emerging therapies, such as novel uricosurics (e.g. verinurad, arhalofenate) and pegloticase, are being developed and may offer alternative treatment options for patients with acute gout 4, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Optimisation of the treatment of acute gout.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2000

Research

An update on the pharmacotherapy of gout.

Expert opinion on pharmacotherapy, 2025

Research

Gout--what are the treatment options?

Expert opinion on pharmacotherapy, 2009

Research

What's new on the front-line of gout pharmacotherapy?

Expert opinion on pharmacotherapy, 2022

Research

Interleukin-1 inhibitors for acute gout.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.